MAG Optics
Private Company
Funding information not available
Overview
MAG Optics is a private, pre-revenue medical device innovator developing a novel intra-corneal implant platform to treat Keratoconus and other refractive errors. Founded in 2003 and based in Rochester, NY, the company's approach aims to transform irregular corneas by applying personalized biomechanical forces, addressing a significant unmet clinical need. The technology has shown promise in early data for improving corneal regularity and alignment, and the company has gained recognition through awards and residency at Johnson & Johnson Innovation JLABS.
Technology Platform
Patient-centric corneal re-shaping platform using an intra-corneal implant designed to apply personalized, directed biomechanical forces to reshape irregular corneas, addressing conditions like Keratoconus and Presbyopia.
Opportunities
Risk Factors
Competitive Landscape
In Keratoconus, competition includes corneal collagen cross-linking (CXL) devices (e.g., Avedro's KXL), intracorneal ring segments (ICRS), specialized contact lenses, and corneal transplants. In the broader refractive market, competition is intense from laser vision correction (LASIK/PRK), phakic IOLs, and presbyopia-correcting IOLs from giants like Alcon, J&J Vision, and Bausch + Lomb.